Redeye updates its estimates following Pagero’s Q3 2023 report, which was more or less in line on the ARR and sales side, while margins were somewhat better than expected. Parts of the better margins were due to seasonality effects related to Q3 being a vacation quarter. We only make minor changes to our estimates.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/